Medicine has been at the forefront of recent advances in artificial intelligence (AI), from image recognition to generative AI. Watch leaders in AI, ethics, and health as they discuss the...

Hastings Center President Vardit Ravitsky will discuss “Constructing an Ethics Framework for AI in Biomedical Research,” or ethics at the intersection of artificial intelligence and health care, at the 2024 Rothenberg...

Fast-moving developments in artificial intelligence have far-reaching implications for caregivers, patients, and the entire healthcare system. Will the introduction of AI systems improve diagnosis, treatment, and research, bringing better and...

Ethics, AI, and Society Increased attention to the widespread applications of artificial intelligence—and large language models such as ChatGPT in particular—has raised questions about the integration of AI into caregiving...

In January, right before President Biden took office, the Food and Drug Administration proposed permanently exempting “software as a medical device” from regulatory review. The agency waived the approval process last year to streamline regulatory oversight during the Covid emergency. But the growing use of artificial intelligence programs and digital devices in health care raises safety and ethical concerns that require more attention. The Biden administration put the proposal on hold for now. Meanwhile, bioethicists should weigh in as the FDA reviews its action plan.

There is big money in using technology to find information in patient and medical staff data. Companies are rushing to cash in. The Food and Drug Administration has approved more than 40 artificial intelligence-based products for use in medicine. Tens of thousands of medical phone apps are tracking patients and gathering detailed medical information about them. These new technologies bring new ethical questions that health care organizations are poorly equipped to answer.

The creation of humanlike intelligence in a nonbiological being would be the greatest achievement in human history. Many experts believe this will happen within decades. What role should, or could, regulatory bodies play?